Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Uber

The partnership will give people in underserved communities free rides to Walgreens vaccine clinics.

Uber, Walgreens team up to get people to COVID-19 vaccine appointments

Walgreens and Uber are teaming up to make it easier for people who do not have a car or a pharmacy nearby.

Uber will offer free rides to Walgreens to expand access to Covid vaccines

Walgreens (WBA) reported earnings 30 days ago. What's next for the stock?

Why Is Walgreens (WBA) Up 10.1% Since Last Earnings Report?

Carrier Global

Clorox

Chevron

Hormel Foods

Coca-Cola

NextEra Energy

ProShares S&P 500 Dividend Aristocrats ETF

Otis Worldwide

Raytheon Technologies

SPDR S&P 500 ETF Trust

Exxon Mobil

Components of the S&P 500 that have paid steadily increasing dividends for at least 25 years have outperformed the broader market over time.

Dividend Aristocrat Performance: January 2021

The Walgreens Boots Alliance will give Roz Brewer a signing bonus worth nearly $25 million when she joins the company as CEO in March, and she'll also be able to use the drugstore chain's private jet for her personal use. Brewer, current chief operating officer at Starbucks and former CEO of Sam's Club, will get a one-time bonus of $4.5 million and $20.2 million in Walgreens stock, alongside her $1.5 million annual salary, per an SEC filing from Walgreens first reported by Fox Business.

Roz Brewer will get a signing bonus worth $25 million when she joins Walgreens as its new CEO, on top of her $1.5 million salary

Walgreens executive Rick Gates reacts to news of the Biden administration directly distributing Covid vaccines to retail pharmacies starting next week.

Covid vaccine will be administered in ‘safe and appropriate places,' assures Walgreens executive

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens has been selected by the Centers for Disease Control and Prevention (CDC) and U.S. Department of Health and Human Services to provide a limited number of COVID-19 vaccinations across 15 states and jurisdictions as part of the Federal Retail Pharmacy Program. Vaccinations will begin in stores Feb. 12 to eligible individuals based on state and jurisdiction guidelines, and may include healthcare workers, people ages 65 and older, and individuals with pre

Walgreens to Expand COVID-19 Vaccinations in Stores as Part of Federal Retail Pharmacy Partnership Program

Amazon

CVS Health

Safety and efficacy requirements and endless regulatory barriers mean that it's actually pretty tough to disrupt the healthcare sector -- even for companies with seemingly endless resources.

Investors Take Note: These Are the Biggest Challenges Facing Healthcare Disruptors

Salesforce

Travelers

Visa

Pessimists have piled into these five brand-name companies.

5 Dow Stocks With the Highest Short Interest

Alexion Pharma

AT&T

Vertex Pharmaceuticals

Verizon

You can still find deeply discounted stocks if you do a little digging.

3 Industries That Are Screaming Bargains in an Otherwise Pricey Market

Roz Brewer Is New CEO Of Walgreens Walgreen Boots Alliance (WBA) has named Roz Brewer as CEO as of March 15, 2021.

Roz Brewer Is New CEO Of Walgreens

Con Ed

Kimberly-Clark

Novo Nordisk

Walmart

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

While stocks keep going up and up, more risks are mounting under the surface. As such, you should be looking at safe stocks to buy now.

7 Safe Stocks to Buy for Solid Returns in Tumultuous Times

Walgreens stock was up nearly 5% in Wednesday trading after the news

The Ratings Game: Starbucks exec & Amazon director Rosalind Brewer brings digital prowess to Walgreens CEO role

Walgreens Boots shares rallying after announcement of new CEO

WASHINGTON, Jan. 27, 2021 /PRNewswire/ -- On behalf of our more than 800 members, including our nearly 350 Black women executives, The Executive Leadership Council (ELC) congratulates Rosalind Brewer on her appointment to CEO of Walgreens and commends the company's decision in selecting a...

Executive Leadership Council Statement on Historic Appointment of Rosalind Brewer as Walgreens CEO

Starbucks

Starbucks Corporation (NASDAQ: SBUX) has lost its COO Rosalind Brewer, who accepted the CEO title at Walgreens Boots Alliance Inc (NASDAQ: WBA). What Happened: Brewer was the CEO of Sam's Club before joining Starbucks as COO and member of the board.

Walgreens Investors Are Loving Their New Starbucks And Sam's Club-Bred CEO

Walgreens' stock price got a boost Wednesday with Starbucks honcho Roz Brewer poised to take over as the pharmacy chain's new CEO. Shares in the Illinois-based drugstore giant jumped 4.6 percent to $51.46 in premarket trading as of 8:25 a.m.

Walgreens stock spikes after tapping Starbucks exec Roz Brewer as new CEO

Rosalind Brewer, Starbucks' operating chief, has now accepted a job as Walgreens Boots Alliance's chief executive, according to The Wall Street Journal (WSJ). She will be the first black woman to lead a Fortune 500 company.

Walgreens Taps Starbucks COO Roz Brewer As New CEO

Walgreens Boots Alliance said on Tuesday that outgoing Starbucks Chief Operating Officer Roz Brewer has been appointed as the company's chief executive officer.

Walgreens names outgoing Starbucks COO Roz Brewer as CEO

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance today announced the appointment of Rosalind (Roz) Brewer as the company's Chief Executive Officer, effective on March 15.

Walgreens Boots Alliance Appoints Rosalind Brewer as Chief Executive Officer, and Stefano Pessina as Executive Chairman of the Board

Starbucks COO Roz Brewer will be the new CEO of drugstore giant Walgreens, the Wall Street Journal reported Tuesday.

Starbucks COO and Amazon board member Roz Brewer will be new Walgreens CEO

Walgreens Boots Alliance appears close to naming Starbucks Corp. operating chief Rosalind Brewer as its next chief executive, according to media reports.

Report: Walgreens To Tap Starbucks COO As New Chief Executive

Walgreens Boots Alliance Inc. is to name a departing Starbucks Corp. executive its new CEO, the Wall Street Journal reported late Tuesday, citing people familiar with the matter. Earlier Tuesday, the coffee chain announced that Chief Operating Officer Roz Brewer was leaving the company to serve as CEO of an undisclosed publicly traded company at the end of February.

Walgreens Boots Alliance to name Starbucks executive its CEO: WSJ

Walgreens is a major pharmaceutical retailer that provides therapeutic, health, and beauty products globally that has recently experienced declines from the global healthcare crisis over the last year. However, Walgreens is expected to see strong recovery due to its store expansions, streamlining its business, and cost-cutting measures. Furthermore, Walgreens currently has an appealing valuation and dividend yield.

Walgreens: A Pharmaceutical Retailer Dividend Aristocrat Worth Watching

CVS Health and Walgreens say they have met a deadline to deliver the first round of Covid-19 vaccine dosages to long-term care facilities, administering three million vaccinations to elderly and vulnerable Americans.

News for Walgreens Stock (WBA)